Quarterly Report (10-q)

0001683131 false 06/30 2022 Q1 0001683131 2021-07-01 2021-09-30 0001683131 2021-11-12 0001683131 2021-09-30 0001683131 2021-06-30 0001683131 us-gaap:SeriesBPreferredStockMember 2021-09-30 0001683131 us-gaap:SeriesBPreferredStockMember 2021-06-30 0001683131 2020-07-01 2020-09-30 0001683131 us-gaap:CommonStockMember 2019-12-31 0001683131 us-gaap:PreferredStockMember 2019-12-31 0001683131 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001683131 forz:CommonStockToBeIssuedMember 2019-12-31 0001683131 us-gaap:RetainedEarningsMember 2019-12-31 0001683131 2019-12-31 0001683131 us-gaap:CommonStockMember 2020-06-30 0001683131 us-gaap:PreferredStockMember 2020-06-30 0001683131 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001683131 us-gaap:PreferredStockMember 2020-01-01 2020-09-30 0001683131 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001683131 forz:CommonStockToBeIssuedMember 2020-01-01 2020-09-30 0001683131 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001683131 2020-01-01 2020-09-30 0001683131 us-gaap:CommonStockMember 2020-09-30 0001683131 us-gaap:PreferredStockMember 2020-09-30 0001683131 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001683131 forz:CommonStockToBeIssuedMember 2020-09-30 0001683131 us-gaap:RetainedEarningsMember 2020-09-30 0001683131 2020-09-30 0001683131 us-gaap:CommonStockMember 2021-06-30 0001683131 us-gaap:PreferredStockMember 2021-06-30 0001683131 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001683131 forz:CommonStockToBeIssuedMember 2021-06-30 0001683131 us-gaap:RetainedEarningsMember 2021-06-30 0001683131 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001683131 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001683131 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001683131 forz:CommonStockToBeIssuedMember 2021-07-01 2021-09-30 0001683131 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001683131 us-gaap:CommonStockMember 2021-09-30 0001683131 us-gaap:PreferredStockMember 2021-09-30 0001683131 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001683131 forz:CommonStockToBeIssuedMember 2021-09-30 0001683131 us-gaap:RetainedEarningsMember 2021-09-30 0001683131 2020-06-30 0001683131 forz:SharePurchaseAgreementMember forz:ShefaliVibhakarMember us-gaap:CommonStockMember 2021-01-01 2021-01-21 0001683131 forz:SharePurchaseAgreementMember forz:ShefaliVibhakarMember us-gaap:PreferredStockMember 2021-01-01 2021-01-21 0001683131 forz:SharePurchaseAgreementMember forz:ShefaliVibhakarMember 2021-01-01 2021-01-21 0001683131 forz:AcquisitionAgreementMember forz:ForzaniMember 2021-01-01 2021-01-21 0001683131 2021-08-17 0001683131 2021-08-01 2021-08-17 0001683131 us-gaap:LineOfCreditMember forz:TwigaCapitalPartnersMember 2017-11-05 0001683131 us-gaap:LineOfCreditMember forz:TwigaCapitalPartnersMember 2017-11-01 2017-11-05 0001683131 2021-09-01 2021-09-28 0001683131 us-gaap:LineOfCreditMember forz:TwigaCapitalPartnersMember 2021-09-30 0001683131 us-gaap:LineOfCreditMember forz:TwigaCapitalPartnersMember 2021-06-30 0001683131 us-gaap:CommonClassAMember 2021-06-30 0001683131 2021-02-19 0001683131 2021-02-01 2021-02-19 0001683131 us-gaap:SeriesBPreferredStockMember 2021-07-01 2021-09-30 0001683131 forz:AcquisitionAgreementMember forz:ForzaniMember 2021-01-21 0001683131 forz:MrForzaniMember 2021-07-01 2021-09-30 0001683131 2021-08-01 2021-08-23 0001683131 2021-08-01 2021-09-30 0001683131 forz:JohnnyForzaniMember 2021-07-01 2021-08-03 0001683131 forz:GeoffStanburyMember 2021-07-01 2021-08-03 0001683131 forz:TomForzaniMember 2021-07-01 2021-08-03 0001683131 2021-08-03 0001683131 forz:SharePurchaseAgreementMember forz:JohnnyForzaniMember us-gaap:CommonStockMember 2021-01-01 2021-01-21 0001683131 2021-10-20 0001683131 forz:MrStanburyMember 2021-10-01 2021-10-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_________________

FORM 10-Q

_________________

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

_________________

FORZA INNOVATIONS INC.

_________________

Wyoming	000-56131	30-0852686
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation or Organization)	File Number)	Identification No.)

30 Forzani Way NW, Calgary, Alberta T3Z 1L5

(Address of Principal Executive Offices) (Zip Code)

(702) 205-2064
(Registrant’s telephone number, including area code)

___________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: None.

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such ﬁles).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer☐	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes ☐ No ☒

APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of November 12, 2021, the issuer had 291,644,231 shares of its common stock issued and outstanding.

FORZA INNOVATIONS INC.

TABLE OF CONTENTS

PART I
Item 1.	Condensed Unaudited Consolidated Financial Statements	2
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	15
Item 4.	Controls and Procedures	15
PART II
Item 1.	Legal Proceedings	16
Item 1A.	Risk Factors	16
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	16
Item 3.	Defaults Upon Senior Securities	16
Item 4.	Mining Safety Disclosures	16
Item 5.	Other Information	16
Item 6.	Exhibits	16
	Signatures	17

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

FORZA INNOVATIONS INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

Condensed Consolidated Balance Sheets as of September 30, 2021 and June 30, 2020 (Unaudited)	4
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020 (Unaudited)
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2021 and 2020 (Unaudited)
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020 (Unaudited)
Notes to the Condensed Consolidated Financial Statements (Unaudited)	8

FORZA INNOVATIONS INC.

(formerly Genesys Industries, Inc)

BALANCE SHEETS


		September 30, 2021			June 30, 2021
ASSETS		(Unaudited)
Current assets:
Cash	$	5,375		$	13,677
Assets of discontinued operations		—			—
Total current assets		5,375			13,677

Machinery and equipment, net		102,427			108,954
Website, net		13,750			15,250
Assets of discontinued operations		—			—
Total Assets	$	121,552		$	137,881

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	96,335		$	35,400
Accrued interest		66,001			57,649
Convertible note payable, net of discount of $0 and $12,500, respectively		120,000			150,000
Loan Payable		22,729			122,729
Due to related party		55,929			54,833
Total current liabilities		360,994			420,611

Total liabilities		360,994			420,611

Commitments and contingencies		—			—

Stockholders' deficit:
Class B Preferred stock, $0.001 par value, 25,000,000 shares authorized, 10,000,000 issued and outstanding		10,000			10,000
Common stock, $0.001 par value, 700,000,000 shares authorized; 281,544,231 and 281,000,000 shares issued and outstanding, respectively		281,544			281,000
Common stock to be issued		100,000			—
Additional paid-in capital		3,825,006			2,921,000
Accumulated deficit		(4,455,992	)		(3,494,730	)
Total stockholders' (deficit) equity		(239,442	)		(282,730	)
Total Liabilities and Stockholders' Equity	$	121,552		$	137,881

The accompanying notes are an integral part of these unaudited financial statements.

FORZA INNOVATIONS INC.

(formerly Genesys Industries, Inc)

STATEMENTS OF OPERATIONS

(Unaudited)


	For the Three Months Ended September 30,
	2021		2020
Operating Expenses:	$		$
General & administrative expenses		98,360		—
Stock based compensation		854,550		—
Total operating expenses		952,910		—

Loss from operations		(952,910)		—

Other expense:
Interest expense		(8,352)		(1,530)
Debt discount amortization		—		(12,500)
Total other expense		(8,352)		(14,030)

Loss before income taxes		(961,262)		(14,030)

Provision for income taxes		—		—

Net loss from continuing operations		(961,262)		(14,030)
Net income from discontinued operations		—		21,690
Net (Loss) Income	$	(961,262)	$	7,660

Net loss per common share, basic & diluted from continuing operations	$	(0.00)	$	(0.00)
Net income per common share, basic & diluted from discontinued operations	$	—	$	0.00
Net Loss Per Common Share, basic & diluted	$	(0.00)	$	(0.00)

Weighted Common Shares Outstanding, basic & diluted		281,234,197		181,000,000

The accompanying notes are an integral part of these unaudited financial statements.

FORZA INNOVATIONS INC. (formerly Genesys Industries, Inc)

STATEMENT OF STOCKHOLDERS' DEFICIT FOR THE

THREE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020

(Unaudited)


	Common Shares		Common Stock		Preferred		Preferred		Paid in Capital		Common stock to be Issued		Accumulated Deficit			Total
					Shares
Balance, June 30, 2020		18,10,00,000	$	1,81,000		1,00,00,000	$	10,000	$	2,21,000		—	$	(351,590	)	$60,410
Net loss		—		—		—		—		—		—		7,660		7,660
Balance, September 30, 2020		18,10,00,000	$	1,81,000		1,00,00,000	$	10,000	$	2,21,000		—	$	(343,930	)	$68,070


	Common Shares		Common Stock		Preferred Shares		Preferred		Paid in Capital		Common stock to be Issued		Accumulated Deficit			Total
Balance, June 30, 2021		281,000,000	$	281,000		10,000,000	$	10,000	$	2,921,000	$	—	$	(3,494,730	)	$	(282,730	)
Shares issued for conversion of debt		144,231		144		—		—		29,856		100,000		—			130,000
Options exercised – related party		400,000		400						19,600		—		—			20,000
Fair value of options granted		—		—		—		—		854,550		—		—			854,550
Net loss		—		—		—		—		—		—		(961,262	)		(961,262	)
Balance, September 30, 2021		281,544,231	$	281,544		10,000,000	$	10,000	$	3,825,006	$	100,000	$	(4,455,992	)	$	(239,442	)

The accompanying notes are an integral part of these unaudited financial statements.

FORZA INNOVATIONS INC.

(formerly Genesys Industries, Inc)

STATEMENTS OF CASH FLOWS

(Unaudited)


		For the Three Months Ended September 30,
		2021		2020

Cash flows from operating activities:
Net Loss from continuing operations	$	(961,262)	$	(14,030)
Less: income from discontinued operations		-		21,690
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		8,027		—
Debt discount amortization		—		12,500
Stock based compensation		854,550		—
Changes in operating assets and liabilities:
Accounts payable		60,935		—
Accrued interest		8,352		1,530
Operating cash flow from discontinued operations		—		9,589
Net cash (used) provided by operating activities		(29,398)		31,279

Cash flows from investing activities:
Investing cash flow from discontinued operations		—		(27,530)
Net cash used in investing activities		—		(27,530)

Cash flows from financing activities:
Advances from related party		21,096		—
Financing cash flow from discontinued operations		—		8,829
Net cash provided by financing activities		21,096		8,829

Net change in cash		(8,302)		12,578

Cash, beginning of period		13,677		174,879
Less: cash of discontinued operations, end of period		—		(187,457)
Cash of continuing operations at end of period	$	5,375	$	—

Supplemental disclosure of cash flow information:
Cash paid for interest	$	—	$	—
Cash paid for taxes	$	—	$	—

The accompanying notes are an integral part of these unaudited financial statements.

FORZA INNOVATIONS INC.

(formerly Genesys Industries, Inc)

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2021

(Unaudited)

NOTE 1 - NATURE OF OPERATIONS

Forza Innovations Inc. (the “Company”), was incorporated on December 9, 2014 under the laws of the State of Florida. The Company was a diversified multi-industry manufacturer of complex metal components and products. We serve all general industrial markets such as Aerospace, Automotive, Commercial, Food Processing, Industrial, Maritime, Medical, Railroad, Oil and Gas, Packaging, Telecom, Textiles, Robotics, Space Travel, Transportation and many more. We are a vertically integrated precision CNC manufacturing and fabrication company with core emphasis on product design, engineering and precision manufacturing of complex components and products.

On February 5, 2018, the Company formed Genesys Industries, LLC as a wholly owned subsidiary in the state of Missouri.

On January 21, 2021, Shefali Vibhakar, President of the Company closed a Share Purchase Agreement (the “Agreement”) that she entered into with Johnny Forzani to sell all of her 170,000,000 common shares and 10,000,000 preferred shares to Johnny Forzani for cash consideration of $177,000.

Further, as part of the Agreement, Ms. Vibhakar agrees to spin out all of the Company’s assets (except for certain machinery valued at $40,000 – which is subject to a separate purchase agreement) as well as all of the Company’s liabilities (except the Company’s note with Tangiers Capital, LLC). The value date of the assets and liabilities will be January 21, 2021.

On January 21, 2021, a change in control of the Company occurred pursuant to the Agreement. Mr. Forzani now has voting control over 93.9% of the Company’s issued and outstanding common stock.

On January 21, 2021, the Company received the resignation of Shefali Vibhakar as the Company’s President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary and Director and appointed Johnny Forzani as its President, Chief Executive Officer, Treasurer, Chief Financial Officer and Secretary.

Effective January 21, 2021, the Company’s new address is 30 Forzani Way NW, Calgary, Alberta, Canada T3Z 1L5.

On February 17, 2021, the Company filed Articles of Continuance with the Secretary of State for the state of Wyoming. Accordingly, the Company transferred its state of formation from Florida to Wyoming and became a Wyoming entity.

On February 18, 2021, the Company filed a Certificate of Dissolution with the Secretary of State for the State of Florida, effectively dissolving the Company's existence in Florida.

As of June 30, 2021, Forza Innovations has moved out of the precision CNC manufacturing and fabrication business and has moved into the health-tech wearable performance business. The Company has acquired the ownership and rights to certain late developmental stage products, including the J4 Sport, J4 X and J4 Fitbelt. These products are wearable back compression devices, used to relax, warmup, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in temperature of the soft tissues which decreases joint stiffness and relieves inflammation.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at September 30, 2021 and for the related periods presented have been made. The results for the three months ended September 30, 2021 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2021, filed with the Securities and Exchange Commission

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.

Concentrations of Credit Risk

We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.

Cash equivalents

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents for the three months ended September 30, 2021 or the year ended June 30, 2021.

Property, Plant and Equipment

Property and equipment are carried at the lower of cost or net realizable value. Major betterments that extend the useful lives of assets are also capitalized. Normal maintenance and repairs are charged to expense as incurred. When assets are sold or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in operations.

Recently issued accounting pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE 3 - GOING CONCERN

The accompanying unaudited financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As of September 30, 2021, the Company has an accumulated deficit of $4,455,992 ($3,069,884 of which is from the FY 2021 loss on the asset acquisition and disposition of assets).

While the Company is successfully executing its growth strategy, its cash position may not still be sufficient to support the Company’s daily operations without additional financing. While the Company believes in the viability of its strategy to produce sales volume and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenues. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern.

NOTE 4 – PROPERTY, PLANT & EQUIPMENT

Long lived assets, including property and equipment and certain intangible assets to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Impairment losses are recognized if expected future cash flows of the related assets are less than their carrying values. Measurement of an impairment loss is based on the fair value of the asset. Long-lived assets and certain identifiable intangibles to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.

Property and Equipment and intangible assets are first recorded at cost. Depreciation and/or amortization is computed using the straight-line method over the estimated useful lives of the various classes of assets between three and five years. Leasehold improvements are being depreciated over ten years, and the building over twenty years.

Maintenance and repair expenses, as incurred, are charged to expense. Betterments and renewals are capitalized in plant and equipment accounts. Cost and accumulated depreciation applicable to items replaced or retired are eliminated from the related accounts with any gain or loss on the disposition included as income.

Property, Plant and equipment stated at cost, less accumulated depreciation for continuing operations consisted of the following:

Property, Plant & Equipment
	September 30, 2021		June 30, 2021
Machinery and Equipment	$	117,135	$	117,135
Less: accumulated depreciation		14,708		8,118
Fixed assets, net	$	102,427	$	109,017

Depreciation expense

Depreciation expense for the three months ended September 30, 2021 and 2020 was $6,527 and $0, respectively.

Our capitalized software cost, less accumulated amortization consisted of the following:

Software cost
	September 30, 2021
Software	$	18,000
Less: accumulated depreciation		2,750
Software, net	$	15,250

Amortization expense

Amortization expense for the years ended September 30, 2021 and 2020 was $1,500 and $0, respectively.

NOTE 5 – CONVERTIBLE DEBT

On January 2, 2020, the Company executed a 10% convertible promissory note in which it agreed to borrow up to $300,000. The note is convertible at a price per share equal to the lower of (a) the Fixed Conversion Price (which is fixed at a price equal to $0.30); or (b) 80% of the lowest trading price of the Company’s common stock during the 5 consecutive trading days prior to the date on which lender elects to convert all or part of the Note. The initial deposit of $125,000 was made on January 15, 2020 and included a $25,000 OID. As required by ASC 470-20-30-6 the Company recognized and measured the embedded beneficial conversion feature at the commitment date of $200,000 which was credited to paid in capital, a $150,000 debt discount and a $75,000 loss on the issuance of convertible debt. As of September 30, 2021, all of the debt discount has been amortized to interest expense. On August 17, 2021, $30,000 of the note was converted into 144,231 shares of common stock per the terms of the agreement. As of September 30, 2021, there is $120,000 and $47,055 of principal and interest due on this loan, respectively.

NOTE 6 - NOTE PAYABLE

On November 5, 2017, to fund its working capital requirements the Company obtained a Special Line of Credit (“LOC”) also recognized as a Blanket Secured Promissory Note for the total draw down amount of up to $500,000, from Twiga Capital Partners, LLC (“TCP”), an entity controlled by the Company’s former sole officer and largest stockholder, Shefali Vibhakar. This Note is secured by all of the assets of the Company in accordance with the Security Agreement by and between the Company and the Holder dated as of November 5, 2017. The LOC bears interest at 5% per annum and is due on demand. On January 21, 2021, TCP assigned all of its rights, title and interest in the debt to Front Row Seating Inc. On September 28, 2021, $100,000 of the note was converted into 10,000,000 shares of common stock. As of September 30, 2021, the shares have not been issued and are disclosed as common stock to be issued. As of September 30, 2021 and 2020, the Company owed $22,729 and $122,729 of principal and $18,946 and $11,279 of accrued interest, respectively.

NOTE 7 - STOCKHOLDERS’ EQUITY

On February 19, 2021, the Company filed a Definitive 14C in order to ratify the written consent received from one shareholder, holding 96.1% of our voting power to: (1) to amend the Company’s Articles of Incorporation, as amended (the “Articles”) to change our corporate name from Genesys Industries, Inc. to Forza Innovations Inc. (the “Name Change”); (2) to amend the Articles to increase the number of authorized shares of Class A Common Stock we may issue from 100,000,000 to 700,000,000 (the “Share Increase”); and, (3) to increase the number of the Company's total issued and outstanding shares of Class A Common Stock by conducting a forward stock split at the rate of 10 shares every 1 share currently issued and outstanding (the “Forward Split”). All shares through these financial statements have been retroactively adjusted to reflect the forward split.

Common stock

During the quarter ended September 30, 2021, the Company issued 10,144,231 shares of common stock for for conversion of $130,000 of debt. As of September 30, 2021, 10,000,000 shares have not been issued and are disclosed as common stock to be issued of $100,000.

Preferred stock

Preferred stock includes 25,000,000 shares of authorized at a par value of $0.001. Preferred stock includes 25,000,000 shares of Class B authorized at a par value of $0.001. The Preferred Stock constitutes a convertible stock in which (1) one Preferred Share is convertible into (5) five Common Shares. The Preferred Stockholders are entitled to vote on any matters on which the common stockholders are entitled to vote.

NOTE 8 - RELATED PARTY TRANSACTIONS

On January 21, 2021, the Company entered into an acquisition agreement with Mr. Forzani to acquire all of the ownership and the rights to certain late developmental stage products, including the J4 Sport, J4 X and J4 Fitbelt in exchange for the issuance of 10,000,000 common shares. The shares were valued at $0.28, the closing stock price on the date of the agreement, for a total value of $2,800,000. The assets were valued at cost of $95,135, resulting in a loss on asset acquisition of $2,704,865. As a result of this acquisition, the Company is moving out of the precision CNC manufacturing and fabrication business and moving into the health-tech wearable performance business.

During the year ended June 30, 2021, Mr. Forzani advanced the Company $54,833, for general operating expenses, the advance is non-interest bearing and due on demand. During the three months ended September 30, 2021, Mr. Forzani advanced the Company an additional $21,096, for a total due as of September 30, 2021 of $55,929.

On August 23, 2021, Mr. Forzani exercised 400,000 of his options for $20,000.

NOTE 9 – STOCK OPTIONS

On August 3, 2021, the Company granted 1,000,000 options to Johnny Forzani, CEO, 250,000 options to Geoff Stanbury, director, and 250,000 options to Tom Forzani, Director. The options were issued pursuant the Company’s 2021 Equity Award Plan. The options are exercisable at $0.05, are immediately vested and expire in two years.

The aggregate fair value of the 1,500,000 options, totaled $854,550 based on the Black Scholes Merton pricing model using the following estimates: exercise price of $0.05, 0.17% risk free rate, 704.9% volatility and expected life of the options of 2 years.

A summary of the status of the Company’s outstanding stock options and changes during the three months ended September 30, 2021 is presented below:

Schedule of Stock Options Outstanding
Stock Options	Options			Weighted Average Exercise Price		Aggregate Intrinsic Value
Options outstanding at June 30, 2021		—		$	—		—
Granted		1,500,000			0.05		—
Exercised		(400,000	)	$	—
Expired		—		$	—
Options outstanding September 30, 2021		1,100,000		$	0.05
Options exercisable at September 30, 2021		1,100,000		$	0.05	$	187,000

NOTE 10 – DISCONTINUED OPERATIONS

On January 21, 2021, Shefali Vibhakar, President of the Company closed a Share Purchase Agreement (the “Agreement”) that she entered into with Johnny Forzani to sell all of her 17,000,000 common shares and 10,000,000 preferred shares to Johnny Forzani for cash consideration of $177,000.

Further, as part of the Agreement, Ms. Vibhakar agrees to spin out all of the Company’s assets (except for certain machinery valued at $40,000 – which is subject to a separate purchase agreement) as well as all of the Company’s liabilities (except the Company’s note with Tangiers Capital, LLC and Twiga Capital). The value date of the assets and liabilities will be January 21, 2021.

In accordance with the provisions of ASC 205-20, Presentation of Financial Statements, we have separately reported the assets and liabilities of the discontinued operations in the consolidated balance sheets. The income and expenses have been reflected as discontinued operations in the consolidated Statements of Operations for the three months ended September 30, 2020, and consist of the following:


	For the Three Months Ended September 30, 2020
Revenue	$	179,056
Cost of revenue		113,760
Gross Margin		65,296
Operating Expenses:
Payroll expense		15,068
General & administrative expenses		16,335
Total operating expenses		31,403

Income from operations		33,893

Total other expense		(12,203	)

Net income	$	21,690

NOTE 10 - SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were available to be issued and has determined that it has no material subsequent events to disclose in these unaudited financial statements other than the following.

On October 20, 2021, the Company entered into a $3,000,000 equity line financing agreement (the “Investment Agreement”) with Tangiers Global, LLC (“Tangiers”), as well as a registration right agreement related thereto (the “Registration Rights Agreement”). The financing is over a maximum of 36 months. Pursuant to the Registration Rights Agreement, a maximum of 7,000,000 shares of our common stock that we may sell to Tangiers from time to time will be registered by us on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended, for this financing. We are required to use our best efforts to file the Registration Statement within 45 days of the date the Investment Agreement. Subject to the terms and conditions of the Investment Agreement, from time to time, the Company may, in its sole discretion, deliver a Put Notice to Tangiers which states the number of shares that the Company intends to sell to Tangiers on a closing date. The maximum amount of shares of Common Stock that the Company shall be entitled to put to Tangiers per any applicable Put Notice shall be an amount of shares up to or equal to 100% of the average of the daily trading volume of the Common Stock for the 10 consecutive Trading Days immediately prior to the applicable Put Notice Date (the “Put Amount”). The Put Amount has to be at least $5,000 and cannot exceed $300,000, as calculated by multiplying the Put Amount by the average daily VWAP for the 10 consecutive Trading Days immediately prior to the applicable Put Notice Date. The Purchase Price of the shares of our common stock that we may sell to Tangiers will be 80% of the lowest trading price of the Common Stock during the Pricing Period applicable to the Put Notice.

The Company is also required to issue Tangiers 25,000 shares of its Common Stock as a commitment fee which shall be issued and delivered to Investor within 5 Trading Days of the Execution Date. The issuance of the shares to Tangiers will be issued in reliance upon the exemptions from the registration requirements of the Securities Act of 1933, as amended, afforded the Company under Section 4(a)(2) promulgated thereunder.

On October 26, 2021, Mr. Stanbury exercised 100,000 of his options for $5,000.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with our unaudited financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management.

Forward Looking Statements

Certain matters discussed herein are forward-looking statements. Such forward-looking statements contained in this Form 10-Q involve risks and uncertainties, including statements as to:

our future operating results;

our business prospects;

our contractual arrangements and relationships with third parties;

the dependence of our future success on the general economy;

our possible future financings; and

the adequacy of our cash resources and working capital.

These forward-looking statements can generally be identified as such because the context of the statement will include words such as we “believe,” “anticipate,” “expect,” “estimate” or words of similar meaning. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which are described in close proximity to such statements and which could cause actual results to differ materially from those anticipated. Shareholders, potential investors and other readers are urged to consider these factors in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included herein are only made as of the date of this Form 10-Q, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Cautionary Statement:

Statements included in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, in future filings by the Company with the Securities and Exchange Commission, in the Company’s press releases and in oral statements made with the approval of an authorized executive officer that are not historical or current facts are “forward-looking statements.” These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. These risks and uncertainties are described in the Company’s Annual Report on Form 10-K for the year ended June 30, 2020, as well as other filings the Company makes with the Securities and Exchange Commission. The Company wishes to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made and are not predictions of actual future results. The Company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Plan of Operations

As of September 30, 2021, Genesys Industries has moved out of the precision CNC manufacturing and fabrication business and has moved into the health-tech wearable performance business. The Company has acquired the ownership and rights to certain late developmental stage products, including the J4 Sport, J4 X and J4 Fitbelt. These products are wearable back compression devices, used to relax, warmup, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in temperature of the soft tissues which decreases joint stiffness and relieves inflammation.

Results of Operation for the Three Months Ended September 30, 2021 Compared to the September 30, 2020

Revenues and Cost of Revenue

Due to the termination of our CNC manufacturing and fabrication business, we did not have any revenue or cost of revenue from continuing operations for the three months ended September 30, 2021 and 2020.

Operating Expenses from Continuing Operations

Operating expenses from continuing operations for the three months ended September 30, 2021 and 2020, consisted of general and administrative expenses of $98,360 and $0, respectively, General and administrative expenses consisted primarily of accounting and audit fees. During the three months ended September 30, 2021, we incurred $62,900 of audit fees and $3,060 for legal. We also had $8,027 of depreciation and amortization, $20,000 for marketing and $4,372 of miscellaneous general and administrative expense. We had no operating expenses from continuing operations in the prior period.

In the current period we incurred an $854,550 non-cash expense for the issuance of stock options to our officers and directore.

Other Income from Continuing Operations

During the three months ended September 30, 2021, we incurred $8,352 of interest expense. During the three months ended September 30, 2020, we incurred $1,530 of interest expense, and $12,500 of debt discount amortization.

Net Loss from Continuing Operations

Our net loss from continuing operations for the three months ended September 30, 2021 was $961,262 compared to $14,030 for the prior period.

Liquidity and Capital Resources

As reflected in the accompanying financial statements, the Company has an accumulated deficit of $4,455,992 at September 30, 2021, and had a net loss from continuing operations of $961,262for three months ended September 30, 2021.

For the three months ended September 30, 2021, we used $29,398 of cash in operating activities, compared to receiving $31,279 for the three months ended September 30, 2020.

We neither received or used any cash in investing activities from continuing operations for the three months ended September 30, 2021 or 2020.

Net cash received from financing activities for the three months ended September 30, 2021 was $21,096 compared to $0 provided by financing activities in the prior period.

Critical Accounting Estimates and Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Note 1 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial Statements. Estimates are used for, but not limited to, contingencies and taxes. Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Financial Statements.

We are subject to various loss contingencies arising in the ordinary course of business. We consider the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies. An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. We regularly evaluate current information available to us to determine whether such accruals should be adjusted.

We recognize deferred tax assets (future tax benefits) and liabilities for the expected future tax consequences of temporary differences between the book carrying amounts and the tax basis of assets and liabilities. The deferred tax assets and liabilities represent the expected future tax return consequences of those differences, which are expected to be either deductible or taxable when the assets and liabilities are recovered or settled. Future tax benefits have been fully offset by a 100% valuation allowance as management is unable to determine that it is more likely than not that this deferred tax asset will be realized.

Off-Balance Sheet Arrangements

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

Recent Accounting Pronouncements

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “SEC”), and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, they concluded that our disclosure controls and procedures were effective for the quarterly period ended September 30, 2021.

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs.

Changes in Internal Controls

Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that no change occurred in the Company's internal controls over financial reporting during the quarter ended September 30, 2021, that has materially affected, or is reasonably likely to materially affect, the Company's internal controls over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

There are not presently any material pending legal proceedings to which the Company is a party or as to which any of our property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINING SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS

No.	Description
31.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
32.1	Certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Label Linkbase Document
101.PRE	XBRL Taxonomy Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Forza Innovations Inc.

Date: November 15, 2021	/s/ Johnny Forzani Johnny Forzani
	President, Chief Financial Officer, Treasurer, Chief Financial Officer, Secretary (Principal Executive, Financial and Accounting Officer)